Longevity Health Holdings Inc.
Price Action
Technical Summary
CONSOLIDATINGLongevity Health Holdings Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 28), showing significant lag compared to the market leaders. Earnings contraction of 9% provides fundamental context to the price action. Investors should exercise caution due to high volatility (207% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.29 | +15.42% | ABOVE |
| 50 SMA | $0.32 | +4.92% | ABOVE |
| 100 SMA | $0.32 | +7.52% | ABOVE |
| 150 SMA | $0.36 | -4.94% | BELOW |
| 200 SMA | $0.57 | -40.75% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is XAGE in an uptrend right now?
XAGE has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is XAGE overbought or oversold?
XAGE's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.
Is XAGE outperforming the market?
XAGE has a Relative Strength (RS) Rating of 28 out of 99. XAGE is currently lagging the broader market.
Where is XAGE in its 52-week range?
XAGE is trading at $0.34, which is 4% of its 52-week high ($8.27) and 1% above its 52-week low ($0.23).
How volatile is XAGE?
XAGE has a Beta of 1.45 and 52-week volatility of 207%. It's more volatile than the S&P 500 - expect bigger swings.